tandardized Cannabis in Multiple Sclerosis: A Case Report (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?toolubmed
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?toolmcentrez
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?toolubmed
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. (abst – 2010) http/www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (abst – 2010) http/msj.sagepub.com/cgi/content/abstract/16/6/707?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/20353778
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration. (abst - 2010) http/www.ncbi.nlm.nih.gov/pubmed/20875047
Julie Falco brings hope to Multiple Sclerosis patients. Cannabinoids manage pain and promote repair! (news – 2010) http/www.examiner.com/x-19678-Cannabis-Revolution-Examiner~y2010m2d10-Julie-Falco-brings-hopeto-Multiple-Sclerosis-patients-Cannabinoids-manage-pain-and-promote-repair
Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study (news – 2010) http/www.news-medical.net/news/20100807/Drugs-that-reduce-activity-of-ABDH6-enzyme-can-preventbrain-damage-Study.aspx
Nature's (Legal) Cannabinoids (news – 2010) http/www.mapinc.org/drugnews/v10/n126/a04.html?1194
Marijuana and MS--an unfinished story. (news – 2010) http/www.thefreelibrary.com/Marijuana+and+MS--an+unfinished+story.-a0237205183
Weed Control Part 1: MS sufferer finds relief with medical marijuana (anecdotal/news – 2010) http/www.theweeklyweedonline.com/weed-control-part-1-ms-sufferer-finds-relief-with-medicalmarijuana/
Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors. (full – 2011) http/www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/
Gadolinium-HU-308-incorporated micelles. (full – 2011) http/www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3060486/
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF – 2011) http/www.dovepress.com/articles.php?article_id=7675
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21094240
Role of cannabinoids in multiple sclerosis (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21323391
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21310467
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(® ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. (abst – 2011) http/www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
Treating pain in multiple sclerosis. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21916786
THC and CBD oromucosal spray (Sativex® in the management of spasticity associated with multiple sclerosis. (abst – 2011) http/www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_th e_management_of_spasticity_associated_with_multipl e_sclerosis_
New metabolic pathway for controlling brain inflammation (news – 2011) http/www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-braininflammation.aspx
Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news – 2011) http/www.alphagalileo.org/ViewItem.aspx?ItemId=113766&CultureCode=en
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial. (full – 2012) http/jnnp.bmj.com/content/83/11/1125.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. (full – 2012) http/www.cmaj.ca/content/184/10/1143.long
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid modulation of neuroinflammatory disorders. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects. (abst - 2012) http/www.ncbi.nlm.nih.gov/pubmed/22342378
Cannabinoid receptor 2 agonists inhibit migration of activated dendritic cells via modulation of MMP-9 (abst – 2012) http/www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/173.23?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22784399
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22583441
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22301508
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22509986
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22509985
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22954177
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22971837
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23011861
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex® for Spasticity in Multiple Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23072659
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23011861?dopt=Abstract
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst – 2012) http/onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
What place for cannabis extract in MS? (abst – 2012) http/dtb.bmj.com/content/50/12/141.abstract
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23180178
A CBâ‚/CBâ‚‚ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22561283
Smoked Cannabis Reduces Some Symptoms of Multiple Sclerosis (news – 2012) http/health.ucsd.edu/news/releases/Pages/2012-05-14-smoked-cannabis-reduces-symptoms-of-multiplesclerosis.aspx
Marijuana Helps Ease MS Symptoms, Study Finds (news – 2012) http/www.healthline.com/health-blogs/study-roundup/marijuana-multiple-sclerosis-101112
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?toolmcentrez
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?toolubmed
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. (abst – 2010) http/www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=314
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (abst – 2010) http/msj.sagepub.com/cgi/content/abstract/16/6/707?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis. (abst – 2010) http/www.ncbi.nlm.nih.gov/pubmed/20353778
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration. (abst - 2010) http/www.ncbi.nlm.nih.gov/pubmed/20875047
Julie Falco brings hope to Multiple Sclerosis patients. Cannabinoids manage pain and promote repair! (news – 2010) http/www.examiner.com/x-19678-Cannabis-Revolution-Examiner~y2010m2d10-Julie-Falco-brings-hopeto-Multiple-Sclerosis-patients-Cannabinoids-manage-pain-and-promote-repair
Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study (news – 2010) http/www.news-medical.net/news/20100807/Drugs-that-reduce-activity-of-ABDH6-enzyme-can-preventbrain-damage-Study.aspx
Nature's (Legal) Cannabinoids (news – 2010) http/www.mapinc.org/drugnews/v10/n126/a04.html?1194
Marijuana and MS--an unfinished story. (news – 2010) http/www.thefreelibrary.com/Marijuana+and+MS--an+unfinished+story.-a0237205183
Weed Control Part 1: MS sufferer finds relief with medical marijuana (anecdotal/news – 2010) http/www.theweeklyweedonline.com/weed-control-part-1-ms-sufferer-finds-relief-with-medicalmarijuana/
Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors. (full – 2011) http/www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3165959/
Gadolinium-HU-308-incorporated micelles. (full – 2011) http/www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3060486/
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF – 2011) http/www.dovepress.com/articles.php?article_id=7675
Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21094240
Role of cannabinoids in multiple sclerosis (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21323391
Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21310467
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(® ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. (abst – 2011) http/www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
Treating pain in multiple sclerosis. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21916786
THC and CBD oromucosal spray (Sativex® in the management of spasticity associated with multiple sclerosis. (abst – 2011) http/www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_th e_management_of_spasticity_associated_with_multipl e_sclerosis_
New metabolic pathway for controlling brain inflammation (news – 2011) http/www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-braininflammation.aspx
Scripps Research Scientists Discover Inflammation Is Controlled Differently in Brain and Other Tissues (news – 2011) http/www.alphagalileo.org/ViewItem.aspx?ItemId=113766&CultureCode=en
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3408184/
Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial. (full – 2012) http/jnnp.bmj.com/content/83/11/1125.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. (full – 2012) http/www.cmaj.ca/content/184/10/1143.long
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid modulation of neuroinflammatory disorders. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects. (abst - 2012) http/www.ncbi.nlm.nih.gov/pubmed/22342378
Cannabinoid receptor 2 agonists inhibit migration of activated dendritic cells via modulation of MMP-9 (abst – 2012) http/www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/173.23?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22784399
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22583441
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22301508
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22509986
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22509985
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22954177
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22971837
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23011861
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex® for Spasticity in Multiple Sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23072659
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23011861?dopt=Abstract
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst – 2012) http/onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
What place for cannabis extract in MS? (abst – 2012) http/dtb.bmj.com/content/50/12/141.abstract
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23180178
A CBâ‚/CBâ‚‚ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22561283
Smoked Cannabis Reduces Some Symptoms of Multiple Sclerosis (news – 2012) http/health.ucsd.edu/news/releases/Pages/2012-05-14-smoked-cannabis-reduces-symptoms-of-multiplesclerosis.aspx
Marijuana Helps Ease MS Symptoms, Study Finds (news – 2012) http/www.healthline.com/health-blogs/study-roundup/marijuana-multiple-sclerosis-101112